Nordisk Pharma ApS — Credit Rating and Financial Key Figures

CVR number: 42852287
Stenkløvervænget 21, 2625 Vallensbæk

Income statement (kDKK)

20222023
Fiscal period length1212
Net sales
Gross profit-18.80331.91
EBIT-18.80331.91
Other financial expenses-0.20
Pre-tax profit-19.00331.91
Income taxes-68.93
Net earnings-19.00262.98

Assets (kDKK)

20222023
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Raw materials and consumables60.38
Inventories total60.38
Current trade debtors250.12
Current other receivables0.58
Short term receivables total0.58250.12
Cash and bank deposits320.44436.10
Cash and cash equivalents320.44436.10
Balance sheet total (assets)321.02746.60

Equity and liabilities (kDKK)

20222023
Share capital340.00340.00
Retained earnings-19.00
Profit of the financial year-19.00262.98
Shareholders equity total321.00583.98
Non-current liabilities total
Current trade creditors16.25
Short-term deferred tax liabilities68.93
Other non-interest bearing current liabilities0.0377.45
Current liabilities total0.03162.62
Balance sheet total (liabilities)321.02746.60
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.